New aspects in the pathogenesis of diabetic atherothrombosis

被引:277
作者
Moreno, PR
Fuster, V
机构
[1] CUNY Mt Sinai Sch Med, Zena & Michael Wiener Cardiovasc Inst, New York, NY 10029 USA
[2] Univ Kentucky, Gill Heart Inst, Lexington, KY 40506 USA
关键词
D O I
10.1016/j.jacc.2004.07.060
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes mellitus is increasing worldwide, resulting from the interaction of obesity, inflammation, and hyperglycemia. Activated immunity and cytokine production lead to insulin resistance and other components of the metabolic syndrome, establishing the link between diabetes and atherosclerosis. Hyperglycemia-induced endothelial dysfunction is mediated by increased oxidative stress, a promoter of adventitial inflammation and vasa vasorum neovascularization in experimental models of diabetic atherosclerosis. Recent studies have documented increased inflammation, neovascularization, and intraplaque hemorrhage in human diabetic atherosclerosis. This inflammatory microangiopathic process is independently associated with plaque rupture, leading to coronary thrombosis. Tissue factor, the most potent trigger of the coagulation cascade, is increased in diabetic patients with poor glycemic control. Circulating tissue factor microparticles are also associated with apoptosis of plaque macrophages, closing the link among inflammation, plaque rupture, and blood thrombogenicity. High-density lipoproteins, responsible for free cholesterol removal, are reduced in patients with insulin resistance and diabetes. High-density lipoprotein therapy leads to a significant decrease in plaque macrophages and increase in smooth-muscle cells. These beneficial effects may be responsible for coronary plaque stabilization in patients treated with recombinant Apolipoprotein A-I Milano/phospholipid complex. Finally, peroxisomal proliferator-activated receptors (PPARs) are now considered the nuclear transcriptional regulators of atherosclerosis. Three subfamilies, including PPAR-alpha, -delta, and -gamma, have been identified with crucial roles in lipid metabolism, plaque inflammation, expression of adhesion molecules and cytokines, and regulation of matrix metalloproteinases. Multiple experimental studies have documented plaque stabilization with PPAR-gamma agonists, a group of medications holding great promise in the treatment of diabetes atherosclerosis. (C) 2004 by the American College of Cardiology Foundation.
引用
收藏
页码:2293 / 2300
页数:8
相关论文
共 50 条
[41]   New anticoagulants for atherothrombosis [J].
Weitz, J. I. .
ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) :324-325
[42]   New Targets for Atherothrombosis [J].
Mackman, Nigel .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34 (08) :1607-1608
[43]   Platelets and lipoprotein (a): a brief overview of their role in the pathogenesis of atherothrombosis [J].
Milionis, HJ ;
Mikhailidis, DP ;
Winder, AF .
PLATELETS, 1999, 10 (05) :277-284
[44]   New Insights in the Pathogenesis and Treatment of Diabetic Retinopathy [J].
Simo, Rafael .
CURRENT MEDICINAL CHEMISTRY, 2013, 20 (26) :3187-3188
[45]   Dopamine: A New Player in the Pathogenesis of Diabetic Retinopathy? [J].
Ntikoudi, Marianthi ;
Farmaki, Theofano Myrto ;
Tziomalos, Konstantinos .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (23)
[46]   NEW APPROACHES TO THE PATHOGENESIS AND TREATMENT OF DIABETIC MICROANGIOPATHY [J].
JENNINGS, PE ;
BARNETT, AH .
DIABETIC MEDICINE, 1988, 5 (02) :111-117
[47]   New concepts in pathogenesis and treatment of diabetic retinopathy [J].
Spranger, J ;
Pfeiffer, AFH .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2001, 109 :S438-S450
[48]   NEW ULTRASTRUCTURAL APPROACH TO PATHOGENESIS OF DIABETIC GLOMERULOSCLEROSIS [J].
CAMPEANU, S ;
CAMPEANU, L .
ACTA DIABETOLOGICA LATINA, 1974, 11 (04) :283-295
[49]   CONDYLOMATA ACUMINATA - NEW ASPECTS ON PATHOGENESIS AND THERAPY [J].
ALBRECHT, G .
ZEITSCHRIFT FUR HAUTKRANKHEITEN H&G, 1986, 61 (07) :457-462
[50]   NEW ASPECTS OF HYDROCEPHALUS PATHOGENESIS AND ITS TREATMENT [J].
RICHARD, KE .
MEDIZINISCHE WELT, 1987, 38 (11) :326-332